SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-041924
Filing Date
2021-02-12
Accepted
2021-02-12 17:21:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d79407dsc13g.htm SC 13G 36808
  Complete submission text file 0001193125-21-041924.txt   38049
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91774 | Film No.: 21629794
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Azamian Bobak R. (Filed by) CIK: 0001827672 (see all company filings)

Type: SC 13G